Comparing two anti-nausea drugs for lung cancer treatment
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This study compares two anti-nausea medications, rolapitant and palonosetron, to see how well they prevent nausea and vomiting caused by chemoradiotherapy for lung cancer. It aims to help patients feel more comfortable during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older.
- Have a confirmed lung cancer diagnosis.
- Be scheduled for at least 6 weeks of chemoradiotherapy (chemotherapy plus radiation).
- Chemotherapy must include a drug that commonly causes nausea, like cisplatin (at a high dose).
- Be in generally good health (able to do daily activities) and have adequate organ function.
- Not have brain metastases that cause symptoms like headaches or vomiting.
- Not be currently vomiting or taking certain anti-nausea medications.
- Not be pregnant or breastfeeding.
- Willing to keep a daily log of nausea and vomiting episodes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two medications (fosrolapitant and palonosetron) to prevent severe nausea and vomiting in patients with esophageal or lung cancer who are receiving chemotherapy combined with immunotherapy. If the medications work well, they could help patients feel better during treatment and complete their cancer care more comfortably.
This trial studies whether palonosetron helps prevent nausea and vomiting caused by chemotherapy that has a moderate risk of vomiting. It may help you feel more comfortable during chemo and avoid treatment interruptions from severe nausea.
This trial tests if combining two anti-nausea drugs (olanzapine and palonosetron) can prevent vomiting and nausea without using steroids in people receiving high-dose cisplatin chemotherapy for their first time.
This study tests if two medicines given together, fosaprepitant and palonosetron, can prevent nausea and vomiting caused by strong chemotherapy given over several days. It's for people who have never had chemo before and are about to start a multi-day treatment for a solid tumor.
This study compares two ways of giving anti-nausea medication: one through an IV (drip) and one as a pill. Both are paired with a newer drug to prevent nausea and vomiting caused by chemotherapy in breast cancer patients.
This study tests whether the combination of olanzapine and metoclopramide can prevent nausea and vomiting caused by strong painkillers (opioids) in people with advanced cancer. If you are starting a strong opioid for pain and have not had nausea or vomiting recently, this study may be for you.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.